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Abstract
The azide-alkyne cycloaddition provides a powerful tool for bio-orthogonal labeling of proteins,
nucleic acids, glycans, and lipids. In some labeling experiments, e.g., in proteomic studies
involving affinity purification and mass spectrometry, it is convenient to use cleavable probes that
allow release of labeled biomolecules under mild conditions. Five cleavable biotin probes are
described for use in labeling of proteins and other biomolecules via the azide – alkyne
cycloaddition. Subsequent to conjugation with metabolically labeled protein, these probes are
subject to cleavage with either 50 mM Na2S2O4, 2% HOCH2CH2SH, 10% HCO2H, 95%
CF3CO2H, or irradiation at 365 nm. Most strikingly, a probe constructed around a
dialkoxydiphenylsilane (DADPS) linker was found to be cleaved efficiently when treated with
10% HCO2H for 0.5 h. A model GFP protein was used to demonstrate that the DADPS probe
undergoes highly selective conjugation and leaves a small (143 Da) mass tag on the labeled
protein after cleavage. These features make the DADPS probe especially attractive for use in
biomolecular labeling and proteomic studies.
Introduction
The azide-alkyne cycloaddition is selective, efficient, and broad in scope – a paradigmatic
example of a ‘click’ reaction.1 The discovery that copper catalysis allows the cycloaddition
to be effected under mild conditions2-3 has stimulated numerous studies of labeling of
proteins,4-5 glycans,6-7 lipids8-9 and RNA.10 For example, we recently reported the Bio-
orthogonal Non-Canonical Amino Acid Tagging4 (BONCAT) method for selective
identification of newly synthesized proteins in cells. In the BONCAT approach, newly
synthesized proteins are distinguished from the pre-existing pool of proteins by co-
translational incorporation of a reactive non-canonical amino acid (e.g., L-
homopropargylglycine (1), Figure 1). Azide or alkyne functional groups on the side chains
of such non-canonical amino acids11,12 can serve as bio-orthogonal handles for selective
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conjugation to affinity probes through the copper-catalyzed azide-alkyne cycloaddition
reaction.13 Once conjugated, newly synthesized proteins can be selectively enriched through
conventional affinity purification protocols that exploit the biotin-streptavidin interaction.
Proteins are released from the resin and identified by mass spectrometry. Azide or alkyne
functional groups incorporated into proteins can also be used for cell-selective labeling of
newly synthesized proteins.14,15
Avidin-based isolation of biotin-labeled proteins has found widespread use; however, the
strength of biotin-avidin interaction (Kd ∼ 10-15 mol/L) can make recovery of proteins from
affinity resins challenging. Conventional methods to elute biotinylated proteins from
immobilized avidin include: (i) denaturation of streptavidin by boiling the resin in a
denaturing buffer16 that may include high concentrations of chaotropic salts, (ii) trypsin
digestion of proteins while they are bound to the resin,17 or (iii) elution of proteins with
excess free biotin.18 These protocols can co-elute contaminant proteins by releasing non-
specifically bound proteins and/or naturally biotinylated proteins concurrently with labeled
proteins.19 In addition, some of these methods can cause elution of high levels of resin-
based peptides along with the proteins of interest, resulting in further sample contamination.
For these reasons, additional purification techniques can be required prior to analysis by
mass spectrometry. Furthermore, most biotin probes require “spacers” to ensure accessibility
of the biotin to the avidin on the resin,20 thus these probes can be quite large molecules.
Ideally, any modification of the proteins of interest should be small to facilitate protein
identification by mass spectrometry. These challenges have prompted the proteomics
community to explore the use of cleavable probes.21-25
Cleavable biotin probes often consist of five parts: (i) the reactive handle, (ii) a spacer
between the reactive handle and the cleavable moiety (iii) the cleavable moiety, (iv) a spacer
between the cleavable moiety and biotin and (v) the biotin (Figure 2). In view of the
importance of the copper catalyzed azide–alkyne cycloaddition in bioconjugation,4-10 we
designed a set of azide-functional, cleavable biotin probes, and we sought to compare the
performance of different cleavable moieties embedded between the azide group and the
biotin. An ideal probe would leave behind a small modification on the protein that would not
complicate mass spectrometry; the spacer between the azide and the cleavable moiety
should be designed accordingly. The probe should be cleavable under conditions that are
mild enough to avoid release of streptavidin or of proteins non-specifically bound to the
resin, and that do not modify the proteins in any way. Cleavage must also allow rapid,
efficient protein recovery in a manner that is compatible with downstream analytical
procedures.
Several cleavable biotin probes have been reported previously, including the commercially
available acid-cleavable probe used in the Cleavable Isotope Coded Affinity Tag (cICAT)
method.21 Other probes have used disulfides,22 diazobenzenes that are cleavable under
reducing conditions,15, 23 or photocleavable linkers.24 In order to design the most effective
probe for use in bioconjugation via the azide–alkyne cycloaddition, we explored all of these
cleavage approaches. In addition, we were tempted by the acid- and fluoride-sensitive
silicon-oxygen bond found in a variety of protecting groups used in organic synthesis26 as
well as in the cleavable motifs used in solid phase synthesis.27 Five cleavable biotin probes
of the general structure shown in Figure 2, all bearing an azide group as the reactive site for
bioconjugation, were prepared. Probe performance was evaluated by examining conjugation
to and release from a test protein (GFP) bearing a single copy of the non-canonical amino
acid 1. One probe, designed around the acid sensitive dialkoxydiphenylsilane (DADPS)
motif, was cleaved under especially mild conditions (10% HCO2H, 0.5 h). This probe
exhibits high labeling selectivity, and leaves a small (143 Da) mass tag on the labeled
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protein after cleavage. These features make the DADPS probe especially attractive for use in
proteomics and other biomolecular labeling studies.
Results and discussion
Synthesis of Cleavable Probes
In order to prepare a photocleavable biotin probe, the methyl ketone 324 was obtained in
three steps from commercially available 5-methyl-2-nitrobenzoic acid (2) (Scheme 1).
Radical bromination at the benzylic position followed by azide displacement gave
compound 4 in 75% overall yield. Reduction of the ketone by NaBH4 and reduction of the
azide under Staudinger conditions28 afforded compound 5. Amide formation using the
commercially available NHS-LC-biotin followed by derivatization of the benzylic alcohol
by treatment with disuccinimidyl carbonate and 3-azidopropylamine afforded the desired
photocleavable biotin probe (6).
We then turned our attention to the diazobenzene motif, which is cleavable via reduction
with sodium dithionite (Na2S2O4). Compound 823 was prepared in two steps from 4-
aminobenzoic acid (7, Scheme 2). Amide formation with 3-azidopropylamine introduced the
azide handle, and following Fmoc deprotection with piperidine, the liberated amine was
coupled with NHS-LC-biotin to afford the desired cleavable biotin probe (9).
The acid- and fluoride-sensitivities of the silicon-oxygen bond commonly found in cleavable
protecting groups used in organic synthesis can be tuned by varying the extent of steric
hindrance around the silicon atom.26 In designing a cleavable silane probe, we placed two
phenyl substituents on silicon, reasoning that smaller groups might render the probe prone to
premature cleavage. For the same reason, a tertiary alkoxy group was placed on the biotin
side of the silicon atom. The acid stability of the dialkoxydiphenylsilane motif has been
reported to increase by two orders of magnitude upon replacement of a methoxy group by a
tert-butoxy substituent.29 The biotin NHS ester 10 was treated with 1-amino-2-methyl-
propan-2-ol to afford the tertiary alcohol 11 (Scheme 3). The latter was treated first with
excess dichlorodiphenylsilane (DCDPS) and then with excess 6-azidohexanol to afford the
acid cleavable biotin probe 12 after silica gel chromatography.
The azido disulfide biotin probe 14a was prepared by treating the commercial NHS ester
biotin derivative 13 with 3-azidopropylamine (Scheme 4). An alkynyl disulfide probe (14b)
was prepared by treatment of 13 with propargylamine. Acid-cleavable probe 16 was
prepared by treating the commercially available iodoacetamide biotin derivative 15 of
undisclosed structure with 3-azidopropanethiol (Scheme 5).
Evaluation of Cleavable Probes
With the biotin probes in hand, we proceeded to assess the labeling and cleaving efficiencies
of each probe with a model protein. A His-tagged green fluorescent protein (GFP) 17 was
engineered to contain a single methionine (Met) site, at the initiator position (Scheme 6);
replacement of Met by 1 generated the alkyne-labeled protein 18. Use of a model protein
bearing a single alkyne site reduced complications that might arise from multiple labeling
and cleaving events. The model protein was obtained by established protocols for in vivo
synthesis of proteins containing non-canonical amino acids.17 Briefly, a Met-auxotrophic
strain of Escherichia coli harboring a plasmid coding for IPTG-inducible expression of the
model protein was grown in M9 medium supplemented with all twenty canonical amino
acids and ampicillin. Upon reaching a cell density corresponding to OD600=1.0, cells were
collected by centrifugation and washed twice in chilled 0.9% NaCl solution. Following re-
suspension in M9 medium supplemented with 1 mM 1 and all twenty canonical amino acids
except Met, protein synthesis was induced with IPTG. Following expression, His-tagged
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GFP was isolated by nickel-affinity chromatography under native conditions. Mass
spectrometric analysis of protein 18 showed a single peak at 28092 Da, indicating near-
quantitative replacement of Met by 1; no signal was detected at 28114 Da, the mass of the
Met form of the protein (see supporting information).
Biotinylated proteins 19a-e were obtained by treatment of 18 with each of the biotin probes
(6, 9, 12, 14a, and 16). The Met form of the protein (17) was also treated under the same
reaction conditions with every probe as a selectivity control. Western blot analysis with
fluorescent anti-His antibody was used as a measure of the total protein content of each
sample; fluorescent streptavidin was used to visualize biotinylated protein. Comparison of
the streptavidin signals obtained from the control protein 17 with those from proteins 19a-e
allowed quantitative comparison of the selectivity of the probes (Figure 3 and Table 1).
Probe 14a was significantly less selective than the others (see figure 3, lane 10b), likely due
to disulfide exchange with one of the three cysteine residues on the model protein. The
relative selectivity of probe 14a was therefore arbitrarily designated as unity (see Table 1).
Probes 6, 9 and 16 were of comparable selectivity, showing roughly ten-fold less non-
specific labeling than probe 14a. Silane probe 12 was remarkably more selective (see Table
I), exhibiting selectivity two orders of magnitude higher than that of 14a.
To determine whether cysteine alkylation prior to click chemistry with probe 14b would
reduce non-specific protein labeling by disulfide probes, we evaluated a reduction-alkylation
protocol widely used in mass spectrometry. Disulfide bonds were reduced with β-
mercaptoethanol and the reduced samples were alkylated with iodoacetamide. Using
Western blot analysis, we compared the biotinylation signal from COS7 cell lysates
incubated for 2 h in either methionine or azidohomoalanine (Aha, 21) and then alkylated, or
not, prior to click chemistry with probe 14b. Addition of the alkylation step resulted in
substantial reduction of the biotin signal in the methionine sample. The biotinylation signal
from the Aha sample, however, was not changed by the alkylation step, suggesting that
most, if not all, of the biotinylation signal in Aha samples is derived from conjugation to
Aha residues (Figure 4). The orientation of the click reaction, (i.e., whether the alkyne
functionality was on the probe or on the protein), did not affect the efficiency of the click
chemistry (see supporting information).
Labeled proteins 19a-e were subjected to cleavage conditions to yield 20a-e (Scheme 6).
Previously reported conditions for cleavage of each motif were used.21-23 From a
comparison of streptavidin signals before (samples 19a-e) and after (samples 20a-e)
cleavage, the cleaving efficiency for each probe was calculated as a percentage of the initial
streptavidin signal that remained after cleavage (Figure 3 and Table 1). Probe 9 was the least
efficiently cleaved (see figure 3, lane 6b) with 23.5 ± 5.7% of the streptavidin signal
remaining after one treatment with 50 mM Na2S2O4 for 1 h. Successive treatments with
Na2S2O4 might have resulted in more complete cleavage,30 but we were interested in
comparing the probes after a single exposure to the cleaving reagent. The streptavidin signal
remaining after cleavage was less than 3% for all of the other probes (6, 12, 14a, 16).
Remarkably, cleavage of the DADPS probe 12 was efficient even upon treatment with 10%
formic acid. In contrast, the other acid-cleavable probe (16) required treatment with 95%
trifluoroacetic acid.
The acid sensitivity of probe 12 was evaluated by treatment of labeled GFP with aqueous
solutions of formic acid of increasing concentration. Use of 10% HCO2H for 0.5 h at room
temperature resulted in >98% cleavage (Figure 5). Treatment with 5% HCO2H cleaved the
probe with 95% efficiency, see Table 1). No significant cleavage of probe 12 was observed
upon treatment with aqueous KF solutions of concentrations up to 5 M (data not shown).
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DADPS probe 12 was examined further with the objective of developing optimized
procedures for enrichment of Hpg-tagged proteins. A GFP variant containing seven Hpg
residues was used in this experiment to enable direct observation of labeled amino acid
residues by mass spectrometry.31 The protein was treated with probe 12 under the conditions
recommended by Finn and coworkers for copper-catalyzed azide–alkyne bioconjugation.32
After successful click reaction, two additional proteins were added to serve as positive and
negative controls for binding to the streptavidin resin. Bovine serum albumin (BSA) was
used as negative control to assess the removal of non-specifically bound proteins from the
resin. Biotinylated horseradish peroxidase (HRP) was used as a positive control for resin
binding, and also served to test if treatment with 5% formic acid would elute endogenous
biotinylated proteins commonly found in cellular proteomes. After click chemistry, excess
12 was removed with a PD10 salt exchange column, and proteins were resuspended in
phosphate buffered saline (PBS) at pH 7.4 with 0.1% SDS and treated with streptavidin
beads. After binding, the beads were washed sequentially with 1% SDS in PBS, 6 M urea in
250 mM ammonium bicarbonate and 1 M NaCl in PBS to remove non-specifically bound
proteins. The last wash contained 0.1% SDS in water to remove remaining salts from the
resin before acid elution. Probe 12 was cleaved by incubating the resin in 5% formic acid in
water for 2 h. The resin was washed twice with water containing 0.1% SDS to remove acid
and four times with 1% SDS in PBS. These elution fractions were combined. Finally the
resin was boiled for 10 min in 2% SDS in PBS.
Figure 6A shows the results of the affinity purification of 7-Hpg-GFP from a solution
containing BSA and biotinylated HRP. As expected, 7-Hpg-GFP treated with probe 12 was
bound to the resin throughout all washes, and then efficiently recovered after treatment with
acid. Subsequent boiling of the resin with 2% SDS in PBS released no additional 7-Hpg-
GFP, indicating that the majority of the protein was eluted following acid cleavage of the
probe. In contrast, most of the biotinylated HRP was recovered only by boiling the resin in
2% SDS. These results show that Hpg-tagged proteins can be separated cleanly from both
non-specifically bound (i.e., non-biotinylated) and endogenously biotinylated proteins.
Probe 12 was used to enrich Hpg-tagged GFP from a bacterial cell lysate. 7-Hpg-GFP was
added to a lysate of E. coli strain DH10B cells; the lysate was then subjected to conjugation
with probe 12. The wash conditions described above were used to remove nonspecifically
bound proteins; the remaining bound proteins were then eluted with 5% formic acid. Figure
6B shows the result. The GFP lane shows the position of GFP before probe conjugation. The
elution lane shows clean enrichment of GFP from the complex lysate. After boiling the resin
with 2% SDS we did not observe elution of more GFP, indicating efficient cleavage of 12
and elution of proteins upon treatment with 5% formic acid. The absence of significant
bands corresponding to lysate proteins in both the elution fraction indicates the specificity of
the enrichment strategy.
Tandem mass spectrometry was used to verify directly the conjugation and cleavage of
probe 12. Peptides resulting from tryptic digestion of eluted proteins were desalted by HPLC
prior to analysis by mass spectrometry. Peptides derived from the control protein (7-Met-
GFP) showed mass shifts of +16 daltons, consistent with oxidation of methionine. Peptides
derived from 7-Hpg-GFP showed shifts of +121 daltons, corresponding to replacement of
methionine by Hpg and subsequent conjugation and cleavage of 12 at Hpg sites (see
supplementary information). The use of formic acid to cleave probe 12 works well for mass
spectrometry by reducing sample complexity and the need for gel extraction. The small
mass modification resulting from attachment and cleavage of the probe can serve as an aid
in identification of Hpg-tagged proteins.
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Conclusion
Five cleavable biotin probes were synthesized and their protein labeling selectivity and
cleaving efficiencies were compared. Probe 12, designed around the acid sensitive
dialkoxydiphenylsilane (DADPS) motif, was found to be the most selective. Efficient
cleavage under mild conditions (10% formic acid, 0.5 h) and the small (143 Da) molecular
fragment left on the labeled protein following cleavage make this probe especially attractive
for use in proteomic studies. Probes 6, 9, 14 and 16 labeled less selectively than 12 in the
experiments reported here, but may prove useful in analyses of other protein populations.
The selectivity of the disulfide probes 14 was improved by a simple reduction-alkylation
protocol that is compatible with proteomic analysis by mass spectrometry. The reactive
probes described here are azides because we are interested in bioconjugation through the
azide-alkyne cycloaddition, but the results should be of general interest with respect to the
design of probes with other reactive groups used in biomolecular labeling studies.
Experimental Section
Synthesis
General—Unless stated otherwise, reactions were performed in flame-dried glassware
under an argon or nitrogen atmosphere using dry solvents. Commercially obtained reagents
were purchased from Sigma-Aldrich and used as received, unless otherwise noted. NHS-LC-
biotin was obtained from Toronto Research Chemicals, homopropargylglycine (1) was
purchased from Chiralix Inc., compounds 10 and 13 were obtained from Pierce Protein
Research Products and compound 15 was obtained from Applied Biosystems. Thin-layer
chromatography was performed using Baker-Flex silica gel IB-F precoated plates and
visualized by UV fluorescence quenching, potassium permanganate, ceric ammonium
molybdate staining or, when the biotin moiety was present, with p-
dimethylaminocinnamaldehyde33 staining solution. EMD Silica gel 60 (particle size
0.040-0.063 mm) was used for flash chromatography. 1H and 13C NMR spectra were
recorded on Varian instruments and chemical shifts are reported relative to Me4Si. Data
for 1H NMR spectra are reported as follows: chemical shift (ppm), integration, multiplicity
and coupling constant (Hz). Multiplicity and qualifier abbreviations are as follows: s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, comp = complex, br = broad, app
= apparent. Low- and high-resolution mass spectra were obtained from the Mass
Spectrometry Facility in the Division of Chemistry and Chemical Engineering at Caltech.
1-(5-Methyl-2-nitrophenyl)ethanone (4)—Compound 324 (3.51 g, 19.6 mmol), N-
bromosuccinimide (3.66 g, 20.6 mmol), and benzoyl peroxide (475 mg, 1.96 mmol) were
refluxed in CC14 (50 mL) overnight. Benzoyl peroxide (238 mg, 0.98 mmol) was added.
After 8 h, the precipitate was filtered off, the filtrate was evaporated under reduced pressure
and the residue was dissolved in EtOAc. The organic phase was washed with saturated
NaHCO3 and with brine, and dried over Na2SO4. After the solvent was evaporated under
reduced pressure, purification by silica gel chromatography using a 10 to 20% gradient of
EtOAc in hexane gave the benzylic bromide (3.61 g, 75%); 1H NMR (300 MHz, CDCl3), δ
(ppm): 8.13-7.91 (1H, m), 7.62 (1H, ddd, J = 20.21, 8.50, 2.00 Hz), 7.49-7.37 (1H, m),
4.55-4.41 (2H, m), 2.65-2.37 (3H, m); 13C NMR (75 MHz, CDCl3), δ (ppm): 199.3, 144.8,
138.4, 131.0-124.8 (m, 4C), 77.2, 30.3; m/z calcd for C9H8BrNO3 [M+H]+: 257.9766, MS
found: 257.0, HRMS found: 257.9773. The benzylic bromide (2.00 g, 7.75 mmol) was
dissolved in acetone:H2O (5:1 by volume, 50 mL). Sodium azide (756 mg, 11.6 mmol) was
added and the mixture was heated to 75 °C overnight in a flask equipped with a reflux
condenser. After acetone evaporation under reduced pressure, the aqueous phase was
extracted with EtOAc, washed with brine and dried with Na2SO4, and the solvent was
evaporated under reduced pressure. Purification by silica gel chromatography using a 10 to
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20% gradient of EtOAc in hexane gave compound 4 (1.65 g, quant); 1H NMR (300 MHz,
CDCl3), δ (ppm): 8.10 (1H, d, J = 8.44 Hz), 7.54 (1H, dd, J = 8.44, 1.92 Hz), 7.35 (1H, d, J
= 1.89 Hz), 4.52 (2H, s), 2.61-2.50 (3H, m); 13C NMR (75 MHz, CDCl3), δ (ppm): 199.5,
142.9, 138.4, 129.6-124.6 (m, 4C), 53.3, 30.1; m/z calcd for C9H8N4O3 [M+H]+: 221.0675,
MS found: 211.3, HRMS found: 221.0679.
1-(5-(Aminomethyl)-2-nitrophenyl)ethanol (5)—Compound 4 (1.50 g, 6.81 mmol)
was dissolved in MeOH:dioxane (3:2 by volume, 30 mL) and NaBH4 (378 mg, 10 mmol)
was added slowly. After 30 min, water (50 mL) and 2M HCl (1 mL) were added and the
suspension was extracted twice with EtOAc, washed with brine, dried over Na2SO4 and
evaporated under reduced pressure and light protection. The resulting brown oil was purified
by silica gel chromatography using a 10 to 20% gradient of EtOAc in hexane to give the
desired alcohol as a pale yellow oil (1.38 g, 91%); 1H NMR (300 MHz, CDCl3), δ (ppm):
7.89 (1H, dd, J = 12.06, 8.10 Hz), 7.79 (1H, dd, J = 8.48, 5.24 Hz), 7.36 (1H, dd, J = 8.37,
2.00 Hz), 5.42 (1H, dd, J = 12.64, 6.33 Hz), 4.47 (2H, s), 1.63-1.43 (3H, m); 13C NMR (75
MHz, CDCl3), δ (ppm): 141.8, 127.4-124.9 (m, 5C), 65.5, 53.9, 24.3; m/z calcd for
C9H10N4O3 [M+H]+: 223.0831, MS found: 222.6, HRMS found: 223.0831. To a solution of
the alcohol (1.00 g, 4.54 mmol) in THF (30 mL), PPh3 (1.31 g, 5.00 mmol) and H2O (0.5
mL) were added and the mixture was heated at 60 °C for 4 h. Evaporation of the solvent
under reduced pressure gave a residue that was dissolved in CH2Cl2 and purified by silica
gel chromatography with 5-15% MeOH in CH2Cl2 to give compound 5 (612 mg, 70%). 1H
NMR (300 MHz, CDCl3), δ (ppm): 7.92-7.72 (2H, m), 7.30 (1H, dd, J = 8.35, 1.88 Hz),
5.39 (1H, q, J = 6.32, 6.32, 6.32 Hz), 4.01-3.83 (2H, m), 1.67-1.37 (3H, m); 13C NMR (75
MHz, CDCl3), δ (ppm): 147.9, 142.2, 126.1-124.4 (m, 4C), 64.8, 45.2, 24.4; m/z calcd for
C9H12N2O3 [M+H]+: 197.0926, MS found: 196.8, HRMS found: 197.0931.
1-(2-Nitro-5-((6-(5-((3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-
yl)pentanamido)hexanamido)methyl)phenyl)ethyl 3-azidopropylcarbamate (6)
—To a solution of NHS-LC-biotin (150 mg, 0.330 mmol) in DMF (5 mL), compound 5 (78
mg, 0.40 mmol) was added followed by Et3N (69 μL, 0.50 mmol). The reaction mixture was
stirred overnight at room temperature, the solvent was evaporated under reduced pressure
and the residue was taken up in CH2Cl2 and purified by silica gel chromatography with a 5
to 15% gradient of MeOH in CH2Cl2 to give the desired amide (144 mg, 81%). m/z calcd for
C25H38N5O6S [M+H]+: 536.2543, MS found: 536.2. To a solution of the amide (117 mg,
0.218 mmol) in DMF (5 mL), N,N′-disuccinimidyl carbonate (84 mg, 0.33 mmol) and Et3N
(91 μL, 0.66 mmol) were added. The next morning, 3-azidopropylamine (110 mg, 1.09
mmol) was added and the mixture was stirred at room temperature for 24 h. The solvent was
evaporated under reduced pressure; the residue was taken up in CH2Cl2 and purified by
silica gel chromatography using a 5 to 10% gradient of MeOH in CH2Cl2. An impurity that
gave a white spot with DACA staining was eluted with 8% MeOH, and the desired
compound 6 (101 mg, 70%) was eluted with 10% MeOH. 1H NMR (300 MHz, MeOH), δ
(ppm): 7.99-7.86 (1H, m), 7.61 (1H, s), 7.38 (1H, dd, J = 8.44, 1.74 Hz), 6.16 (1H, dd, J =
10.82, 4.39 Hz), 4.48 (2H, dd, J = 9.05, 5.91 Hz), 4.29 (1H, dd, J = 7.88, 4.44 Hz),
3.55-3.03 (6H, m), 3.03-2.81 (1H, m), 2.69 (1H, d, J = 12.74 Hz), 2.48 (1H, dd, J = 10.93,
4.01 Hz), 2.42-2.33 (1H, m), 2.28 (2H, t, J = 7.45, 7.45 Hz), 2.18 (2H, dd, J = 12.35, 5.04
Hz), 1.88-1.26 (17H, m); 13C NMR (75 MHz, MeOH), δ (ppm): 174.9, 173.0, 170.3, 164.9,
156.6, 146.7, 145.8, 139.1, 127.1, 125.9, 124.6, 68.3, 62.2, 60.4, 55.9, 42.3, 39.9, 39.0, 37.9,
36.6, 35.7, 30.8, 29.0, 28.9, 28.6, 28.5, 28.3, 28.0, 26.4, 25.8, 25.5, 21.3; m/z calcd for
C29H43N9O7S [M+H]+: 662.3084, MS found: 684.3 (M+Na), HRMS found: 662.3072.
N-(3-Azidopropyl)-4-((2-hydroxy-5-(2-(6-(5-((3aS,4S,6aR)-2-oxo-hexahydro-1H-
thieno[3,4-d]imidazol-4-
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yl)pentanamido)hexanamido)ethyl)phenyl)diazenyl)benzamide (9)—To a
solution of compound 823 (1.50 g, 2.96 mmol) and 3-azidopropylamine (355 mg, 3.55
mmol) in CH2Cl2 (50 mL) was added EDC (850 mg, 4.43 mmol). The next morning, the
organic phase was washed twice with 1M HCl (50 mL) and once with brine, and dried over
Na2SO4. The solvent was evaporated under reduced pressure to give a brown oil that was
dissolved in DMF (25 mL). Piperidine (2.5 mL) was added and the next morning the solvent
was evaporated under reduced pressure. The residue was taken up in CH2Cl2 and purified by
silica gel chromatography using a 10 to 50% gradient of MeOH in CH2Cl2 to give the
desired amine (220 mg, 20% for two steps). m/z calcd for C18H22N7O2 [M+H]+: 368.1835,
MS found: 368.0, HRMS found: 368.1823. To a solution of NHS-LC-biotin (75 mg, 0.17
mmol) in DMF (5 mL), the above-described amine (73 mg, 0.20 mmol) was added followed
by Et3N (35 μL, 0.25 mmol). The next morning, the solvent was evaporated under reduced
pressure and the residue was taken up in CH2Cl2 and purified by silica gel chromatography
with a 5 to 10% gradient of MeOH in CH2Cl2 to give compound 9 (92 mg, 80%). 1H NMR
(300 MHz, MeOH), δ (ppm): 8.82-8.55 (m, 1H), 8.02 (m, 4H), 7.93-7.79 (m, 1H), 7.79-7.65
(m, 1H), 7.56 (s, 1H), 7.42-7.16 (m, 1H), 7.16-6.89 (m, 1H), 6.39 (d, J = 19.06 Hz, 2H),
4.39-4.18 (m, 1H), 4.18-3.99 (m, 1H), 3.71-3.15 (m, 4H), 2.95 (m, 4H), 2.62 (m, 6H), 2.01
(m, 4H), 1.79 (m, 2H), 1.34 (m, 8H); 13C NMR (75 MHz, MeOH), δ (ppm): 173.5, 172.6,
166.3, 163.4, 154.2 153.6, 138.9, 136.9, 135.0, 131.6-129.1 (m, 5C), 123.1, 118.9, 61.7,
59.9, 56.1, 49.2, 37.5, 36.1, 35.9, 34.8, 29.1-28.7 (m, 4C), 26.8, 26.0-25.8 (m, 3C); m/z calcd
for C34H46N10O5S [M+H]+: 707.3452, MS found: 731.1 (M+Na), HRMS found: 707.3462.
N-(2-Hydroxy-2-methylpropyl)-1-(5-((3aS,4S,6aR)-2-oxo-hexahydro-1H-
thieno[3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-tetraoxapentadecan-15-
amide (11)—To a solution of compound 10 (150 mg, 0.255 mmol) in CH2Cl2 (5 mL), 1-
amino-2-methyl-propan-2-ol (27 mg, 0.31 mmol) was added followed by Et3N (42 μL, 0.31
mmol). After 4 h, the solvent was evaporated under reduced pressure and the residue was
taken up in CH2Cl2 and purified by silica gel chromatography with a 15 to 20% gradient of
MeOH in CH2Cl2 to give compound 11 (121 mg, 85%). 1H NMR (300 MHz, CDCl3), δ
(ppm): 7.20 (s, 1H), 7.00 (s, 1H), 6.56 (s, 1H), 5.89 (s, 1H), 5.31 (s, 1H), 4.52 (s, 1H), 4.34
(d, J = 4.58 Hz, 1H), 3.85-3.51 (m, 20H), 3.51-3.36 (m, 3H), 3.26 (d, J = 5.96 Hz, 2H), 3.15
(d, J = 4.36 Hz, 1H), 2.89 (d, J = 4.78 Hz, 1H), 2.52 (t, J = 5.84, 5.84 Hz, 2H), 2.24 (t, J =
7.41, 7.41 Hz, 2H), 1.67 (dd, J = 14.92, 7.45 Hz, 4H), 1.42-1.09 (m, 8H); m/z calcd for
C25H46N4O8S [M+H]+: 563.3115, MS found: 563.2, HRMS found: 563.3089.
N-(4-((6-Azidohexyloxy)diphenylsilyloxy)butyl)-1-(5-((3aS,4S,6aR)-2-oxo-
hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-
tetraoxapentadecan-15-amide (12)—To a solution of dichlorodiphenylsilane (0.19 mL,
0.88 mmol) and Et3N (0.34 mL, 2.4 mmol) in anhydrous CH2Cl2 (20 mL) was added
compound 11 (0.10 g, 0.18 mmol). After 10 h, 6-azidohexanol (0.30 g, 2.2 mmol) was
added. The solvent was evaporated 16 h later, and the residue was taken up in CH2Cl2 and
passed through a silica gel column with 10% MeOH in CH2Cl2. The solvents were
evaporated under reduced pressure and the residue dissolved in CH2Cl2 was washed with a
saturated solution of NaHCO3. The NaHCO3 solution was extracted with CH2Cl2 three
times. The CH2Cl2 fractions were combined and dried over Na2SO4. After removal of
CH2Cl2 under reduced pressure, a second purification by silica gel chromatography with a 2
to 10% gradient of MeOH in CH2Cl2 gave compound 12 (86 mg, 55%). 1H NMR (300
MHz, CDCl3), δ (ppm): 7.62 (dd, J = 7.74, 1.54 Hz, 4H), 7.54-7.20 (m, 6H), 6.83-6.66 (m,
1H), 6.56-6.39 (m, 1H), 5.71-5.47 (m, 1H), 4.54-4.35 (m, 1H), 4.35-4.17 (m, 1H), 3.87-3.45
(m, 20H), 3.41 (dd, J = 5.57, 2.80 Hz, 3H), 3.31 (d, J = 5.98 Hz, 2H), 3.22-3.06 (m, 2H),
2.96-2.78 (m, 1H), 2.72 (s, 1H), 2.40 (t, J = 6.07, 6.07 Hz, 2H), 2.19 (d, J = 7.34 Hz, 2H),
1.82-1.49 (m, 6H), 1.37 (m, 6H), 1.31-1.10 (m, 8H); 13C NMR (126 MHz, CDCl3), δ (ppm):
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173.3, 171.2, 164.0, 134.7 (m, 6C), 130.2 (m, 2C), 127.8 (m, 4C), 75.7, 70.3 (m, 8C), 67.3,
63.0, 61.8, 60.2, 55.6, 51.4, 50.4, 40.5, 39.1, 37.1, 35.9, 32.2, 28.8, 28.2, 27.6, 26.4, 25.6
(2C), 25.3; m/z calcd for C43H67N7O9SSi [M+H]+: 886.4569, MS found: 908.2 (M+Na),
HRMS found: 886.4601.
N-(2-((3-(3-Azidopropylamino)-3-oxopropyl)disulfanyl)ethyl)-1-(5-((3aS,4S,
6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-
tetraoxapentadecan-15-amide (14a)—To a solution of compound 13 (50 mg, 0.067
mmol) in CH2Cl2 (5 mL), 3-azidopropylamine (8.7 mg, 0.086 mmol) was added followed
by Et3N (12 μL, 0.086 mmol). After 2 h, the solvent was evaporated under reduced pressure
and the residue was taken up in CH2Cl2 and purified by silica gel chromatography with a 5
to 12% gradient of MeOH in CH2Cl2 to give compound 14a (39 mg, 80%). 1H NMR (300
MHz, CDCl3), δ (ppm): 7.40 (s, 1H), 7.19 (s, 1H), 7.10-7.01 (m, 1H), 6.55 (s, 1H),
5.99-5.78 (m, 1H), 4.60-4.44 (m, 1H), 4.34 (d, J = 4.42 Hz, 1H), 3.91-3.47 (m, 20H),
3.47-3.23 (m, 5H), 3.15 (d, J = 4.46 Hz, 1H), 3.00 (t, J = 7.00, 7.00 Hz, 2H), 2.95-2.72 (m,
3H), 2.63 (dd, J = 15.62, 8.69 Hz, 2H), 2.51 (t, J = 5.81, 5.81 Hz, 2H), 2.24 (t, J = 7.27, 7.27
Hz, 2H), 2.03-1.56 (m, 6H), 1.45 (d, J = 6.94 Hz, 2H); 13C NMR (75 MHz, CDCl3), δ
(ppm): 173.6, 172.0, 171.4, 164.1, 70.2 (m 8C), 67.2, 61.8, 60.2, 55.7, 49.2, 40.5, 39.2, 38.5,
38.1, 36.8 (2C), 36.4, 35.8, 35.0, 28.7, 28.1, 25.6; m/z calcd for C29H52N8O8S3 [M+H]+:
737.3149, MS found: 759.2 (M+Na), HRMS found: 737.3148.
N-(2-((3-(propargylamino)-3-oxopropyl)disulfanyl)ethyl)-1-(5-((3aS,4S,6aR)-2-
oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-
tetraoxapentadecan-15-amide (14b)—The procedure described above for the
preparation of compound 14a was followed except that 3-azidopropylamine was replaced by
propargylamine, and afforded 14b in 81% yield. 1H NMR (500 MHz, CDCl3), δ (ppm): 6.97
(s, 1H), 6.35 (s, 1H), 5.52 (s, 1H), 4.57-4.44 (m, 1H), 4.33 (dd, J = 7.29, 4.87 Hz, 1H), 4.05
(dd, J = 5.22, 2.49 Hz, 2H), 3.75 (t, J = 5.81, 5.81 Hz, 2H), 3.69-3.60 (m, 16H), 3.56 (m,
4H), 3.44 (dd, J = 7.15, 3.78 Hz, 2H), 3.20-3.07 (m, 2H), 3.03-2.97 (m, 2H), 2.91 (dd, J =
12.80, 4.88 Hz, 1H), 2.85 (t, J = 6.51, 6.51 Hz, 2H), 2.75 (d, J = 12.76 Hz, 1H), 2.65 (t, J =
7.17, 7.17 Hz, 2H), 2.51 (t, J = 5.81, 5.81 Hz, 2H), 2.37-2.16 (m, 4H), 1.82-1.60 (m, 4H),
1.43 (td, J = 21.27, 7.37, 7.37 Hz, 2H), 1.25 (s, 1H); 13C NMR (126 MHz, CDCl3), δ (ppm):
173.5, 172.0, 171.0, 163.9, 80.0, 71.3, 70.2 (m 8C), 67.3, 61.8, 60.2, 55.6, 45.9, 40.6, 39.2,
38.4, 36.9, 36.0, 34.4, 29.1, 28.1, 25.6, 8.6; m/z calcd for C29H49N5O8S3 [M+H]+:
692.2822, MS found: 714.2 (M+Na), HRMS found: 692.2822.
Probe 16—To a solution of 15 (0.5 mg, 0.45 μmol) in acetonitrile (1 mL), 3-
azidopropanethiol (85 μg, 0.7 μmol) was added followed by Et3N (0.10 μL, 0.7 μmol). The
next morning, the solvent was evaporated and H2O (1 mL) was added. Lyophilization of the
sample gave 16 (approx 0.5 mg, quant.). m/z calcd for C48H85N11O9S2 [M+H]+: 1024.6051,
MS found: 1024.1, HRMS found: 1024.6043.
General protocol for click chemistry—Protein 17 or 18 (100 μL of a 0.50 mg/mL 50%
glycerol stock solution) was added to 800 μL of PBS, pH 7.8, followed by SDS (100 μL of a
10% w/v stock solution). The biotin probe (10 μL of a 5 mM stock solution in DMSO) and
the Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine ligand (10 μL of a 20 mM stock
solution in DMSO) were added followed by a freshly prepared and vigorously vortexed
CuBr solution (20 μL of a 3 mg CuBr/mL in H2O stock solution, made from CuBr 99.999%
purchased from Sigma-Aldrich). The mixture was stirred vigorously at 15 °C for 4 h, added
dropwise to a centrifugation tube containing acetone (5 mL) and kept at -20°C for 2 h.
Centrifugation at 2000g for 10 min at 4 °C yielded a pellet that contained protein and
copper; the pellet was resuspended by sonication in 100 μL PBS, pH 7.8, containing 3%
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SDS. Centrifugation at 2000g for 10 min at 4 °C sedimented the copper in the form of a blue
pellet. The supernatant containing the labeled protein was stored at -20 °C until needed.
General protocol for probe cleavage—The reagent required for cleavage of each
probe was added to the corresponding labeled protein sample at room temperature. After the
desired reaction time (see Table 1), aliquots were mixed with SDS gel loading buffer, loaded
on an SDS gel and subjected to western blot analysis as described below.
Western blot analysis—Tris-glycine SDS gels (12% acrylamide) were run (without pre-
boiling the samples) using a Fisher Scientific FB3000 instrument at 165V/250mA for 45
min. Proteins were transferred to a GE Healthcare Life Science Hybond ECL membrane
using a Hoefer Scientific Instruments TE50X at 80 V for 1 h at 4°C. After the membrane
was blocked with 5% milk powder in PBS, pH 7.4, containing 0.5% TWEEN 20, the
residual milk solution was removed by three washes with 10 mL of PBS, pH 7.4, containing
0.5% TWEEN 20. Anti penta-his alexa fluor 488 conjugate (Qiagen, 2 μL, 1:5000) and
streptavidin alexa fluor 633 conjugate (Invitrogen, 4 μL, 1:2500) were added to the
membrane in 10 mL of PBS, pH 7.4, containing 0.5% TWEEN 20. The membrane was kept
in the dark under gentle shaking for 45 min. The residual antibodies were washed five times
with 10 mL of PBS, pH 7.4, containing 0.5% TWEEN 20; fluorescence was measured on a
GE Healthcare Typhoon Trio™ Variable Mode Imager.
Cloning—The previously reported expression vector pQE-80/GFPrmAM30 was subjected
to site-directed mutagenesis to generate the M13L mutation of GFPrmAM, yielding pJS2.
pJS2 encodes a GFP variant that contains only one methionine site, at the N-terminus.
Constructs were confirmed by sequencing.
Protein expression and purification—pJS2 was transformed into the methionine
auxotrophic E. coli strain M15MA/pREP4 and isolated on LB-agar plates containing 35 μg/
mL kanamycin and 200 μg/mL ampicillin. A single colony was used to inoculate an
overnight 5 mL culture in LB containing kanamycin and ampicillin. The following morning,
1 mL of the culture was diluted in 49 mL of M9 minimal medium (M9 salts, 0.2 % glucose,
1 mM MgSO4, 0.1 mM CaCl2, 25 mg/mL thiamine) and supplemented with 40 mg/L of
each of the twenty natural amino acids in addition to kanamycin and ampicillin. Cells were
grown until OD600 reached 1.0 (4-5 h), pelleted at 2000 g for 10 min at 4°C and washed
twice in cold, sterile 0.9% NaCl. Cells were resuspended in M9 (-Met) medium (M9
medium supplemented with 40 mg/L of each of the natural amino acids except methionine).
Either Hpg or methionine was added to a final concentration of 1 mM. IPTG was added to a
final concentration of 1 mM to induce synthesis of GFP. Cells were induced for 4 h at 37°C
and pelleted at 2000 g for 10 min at 4°C; the supernatant was removed and cells were frozen
at -80°C overnight. The His-tagged GFP was purified on a Qiagen NiNTA resin under
native conditions according to the manufacturer's recommendations. The purified protein
was subjected to buffer exchange into PBS, pH 7.8, on GE Healthcare PD10 columns
according to the manufacturer's protocol. Glycerol was added to the protein sample at a final
concentration of 50%, and the protein was stored in 50% glycerol at -20°C until used.
Protein digestion and mass spectrometry—GFP samples (20 μg) were dissolved in 8
M urea in 100 mM Tris-HCl, pH 8.5, and incubated in 3 mM Tris(2-carboxyethyl)phosphine
hydrochloride for 20 min at room temperature. The samples were then treated with 11.5 mM
iodoacetamide for 15 min, followed by Endoprotease Lys-C (Promega) digestion according
to the manufacturer's recommendations. The sample was diluted to 2 M urea with 100 mM
Tris-HCl, pH 8.5, and adjusted to 1 mM CaCl2. Tryptic digestion (Promega) was carried out
according to the manufacturer's recommendations, and was followed by addition of 5%
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formic acid to stop trypsin activity. The resulting peptides were desalted by HPLC (Waters
Corp.) on a C8 peptide microtrap (Michrom Bioresources, Inc.). The peptides were analyzed
on a Thermo Finnigan Orbitrap FT mass spectrometer in positive ion mode with collision-
induced dissociation (CID) for ms/ms analysis.
Iodoacetamide alkylation—COS7 cells were grown to 80% confluence in DMEM++
media. Cells were washed and incubated for 30 min in Hepes-buffered saline, pH 7.4 (HBS),
followed by 2 h incubation in either 4 mM methionine in HBS or 4 mM Aha in HBS. Cells
were pelleted and lysate was prepared as described previously.17 Cell lysate was reduced in
2% β-mercaptoethanol in PBS pH 7.8 for 1 h in the dark at 25°C and then proteins were
precipitated in acetone. Upon resuspension in 250 μL PBS, pH 7.8, proteins were alkylated
by treatment with 11 mM iodoacetamide for 1 h in the dark at 25°C, and then again
precipitated in acetone. After a second resuspension in 500 μL PBS pH 7.8, the click
chemistry reaction was assembled as described previously.17
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Schematic representation of the BONCAT method.
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Figure 2.
Elements of a generic cleavable biotin probe.
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Figure 3.
Anti-His (a) and streptavidin (b) signals to determine the labeling and cleaving efficiencies
of each probe. Lane 1: 17 + 6 treated with click conditions; lane 2: 19a; lane 3: 20a; lane 4:
17 + 9 treated with click conditions; lane 5: 19b; lane 6: 20b; lane 7: 17 + 12 treated with
click conditions; lane 8: 19c; lane 9: 20c; lane 10: 17 + 14a treated with click conditions;
lane 11: 19d; lane 12: 20d; lane 13: 17 + 16 treated with click conditions; lane 14: 19e; lane
15: 20e.
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Figure 4.
Alkylation prior to click chemistry significantly reduces non-specific protein labeling by
probe 14b. COS7 cells incubated in either methionine or Aha were lysed and either not
alkylated (lanes 1 and 2) or alkylated (lanes 3 and 4) prior to reaction with 14b. Western
blots were visualized using an antibody against biotin.
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Figure 5.
Anti-His (a) and streptavidin (b) signals for the cleavage of probe 12 with 10% and 5%
formic acid. Lane 1: 19c not treated with any acid after 5 h; lane 2: 19c treated with 10%
HCO2H for 0.5 h; lane 3: 19c treated with 5% HCO2H for 0.5 h.
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Figure 6.
Polyacrylamide gel analysis of affinity purification of 7-Hpg-GFP. A: After click reaction
with probe 12, affinity purification from a solution containing BSA (band I), biotinylated
HRP (band II), and 7-Hpg-GFP (band III), was performed on a streptavidin agarose resin.
Wash 1 was performed with 1% SDS in PBS; wash 2 with 6 M urea in 250 mM ammonium
bicarbonate; wash 3 with 1 M NaCl in PBS and wash 4 with 0.1% SDS in water to remove
PBS. Elution with 5% formic acid was followed by boiling of resin in 2% SDS in PBS to
remove remaining proteins. B: Affinity purification of 7-Hpg-GFP from a DH10B lysate.
Wash and elution conditions were identical to those in Figure 6A. Gels were stained with
Coomassie Brilliant Blue.
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Scheme 1.
Synthesis of a photocleavable biotin probe.
Reagents and conditions: a) SOCl2; b) Mg, diethyl malonate; c) HCl, 83% for 3 steps; d)
NBS, (BzO)2, 75%; e) NaN3, quant.; f) NaBH4, 91%; g) PPh3, H2O, 70%; h) NHS-LC-
biotin, 80%; i) DSC then 3-azidopropylamine, 70%.
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Scheme 2.
Synthesis of a Na2S2O4 cleavable biotin probe.
Reagents and conditions: a) NaNO2, HCl; b) tyramine, NaHCO3 then Fmoc-Cl, 55% for 2
steps; c) EDC, 3-azidopropylamine; d) piperidine, 20% for 2 steps; e) NHS-LC-biotin, 80%.
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Scheme 3.
Synthesis of the DADPS biotin probe.
Reagents and conditions: a) 1-amino-2-methyl-propan-2-ol, 85%; b) Et3N, DCDPS then 6-
azidohexanol, 55%.
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Scheme 4.
Synthesis of disulfide biotin probes.
Reagents and conditions: a) 3-azidopropylamine, 80%; b) propargylamine, 81%.
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Scheme 5.
Synthesis of the acid cleavable biotin probe.
Reagents and conditions: a) 3-azidopropanethiol, Et3N, quant.
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Scheme 6.
Protein labeling and probe cleavage.
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